MICHAEL ASBURY: Open Payments
NPI 1942483425 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 93 payments from 17 companies in 2025. Trend: 2023 $5,744 · 2024 $10,641 · 2025 $2,371
Food & beverage: $2,286Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $473 |
| E.R. Squibb & Sons, L.L.C. | 17 | $343 |
| Incyte Corporation | 6 | $296 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $191 |
| Novartis Pharmaceuticals Corporation | 7 | $171 |
| ABBVIE INC. | 10 | $156 |
| PFIZER INC. | 6 | $124 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $118 |
| GENZYME CORPORATION | 4 | $115 |
| Lilly USA, LLC | 4 | $85 |
Products named: TREMFYA, Sotyktu, OPZELURA, COSENTYX, DUPIXENT, CIBINQO, Neo-Synalar, ILUMYA.
Industry payments across NC — which companies pay providers there.
